Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study
- DOI
- 10.3389/fonc.2026.1847437
- Published
- 2026-09-04
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1847437,
title = {Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study},
author = {Songshen Liu and Xia Zhao and Xue Shi and Hong Xu and Wei Wang and Lingjie Sun},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1847437},
url = {https://doi.org/10.3389/fonc.2026.1847437}
}RIS
TY - JOUR TI - Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study AU - Songshen Liu AU - Xia Zhao AU - Xue Shi AU - Hong Xu AU - Wei Wang AU - Lingjie Sun PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1847437 UR - https://doi.org/10.3389/fonc.2026.1847437 ER -
APA
Liu, S., Zhao, X., Shi, X., Xu, H., Wang, W., & Sun, L. (2026). Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1847437
Source records
- crossref · retrieved 2026-09-25T07:24:08.636Z